GlaxoSmithKline logo

Audit & Risk Committee

Membership:

Chairman: Tom de Swaan
Members:

Professor Sir Roy Anderson
Stacey Cartwright
Judy Lewent
Sir Deryck Maughan
Dr Daniel Podolsky
Sir Robert Wilson

Secretary: Victoria Whyte
In attendance: Chairman
Chief Executive Officer
Chief Financial Officer
General Counsel
Head of Audit & Assurance
Head of Governance, Ethics & Assurance
Chief Medical Officer
Representative of external auditors
Frequency of meetings: Not less than four times a year


The Audit & Risk Committee reviews the financial and internal reporting process, the integrity of the company’s financial statements, the external and internal audit processes, the system of internal controls and the identification and management of risks. The committee also proposes to shareholders the appointment, re-appointment and removal of the external auditors and is directly responsible for their remuneration and oversight of their work. The committee consists entirely of Independent Non-Executive Directors.

The Audit & Risk Committee's latest report is included in the company's 2010 Annual Report.